Carregant...
Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy
Nine pretreated patients aged >19 years with relapsed/refractory acute lymphoblastic leukemia (ALL) were treated with a combination of bortezomib plus chemotherapy before allogeneic hematopoietic stem cell transplantation (allo-HSCT). Eight (88.9%) patients, including two Philadelphia chromosome-...
Guardat en:
| Publicat a: | Int J Gen Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4472074/ https://ncbi.nlm.nih.gov/pubmed/26109875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S59537 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|